Neoadjuvant chemotherapy for osteosarcoma of the extremities: the Rizzoli Institute experience.
Bacci
G
G
Centro Tumori, Reparto di Chemioterapia, Università Istituto Ortopedico Rizzoli, Bologna, Italy.
Avella
M
M
Picci
P
P
Ruggieri
P
P
Biagini
R
R
Ferruzzi
A
A
Casadei
R
R
Caldora
P
P
Campanacci
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D012516:Osteosarcoma / Q000188:drug therapy*; D011182:Postoperative Care; D011300:Preoperative Care
D004317:Doxorubicin; D002945:Cisplatin; D008727:Methotrexate